ArticleDiscover oncology2026
Primary pulmonary squamous cell carcinoma with colonic metastasis.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer continues to have the highest mortality rate among cancers worldwide. At the time of diagnosis, 50% of lung cancer patients present with locally advanced or distant metastasis, commonly to the brain, bone, liver, and adrenal glands. Lung metastasis to the small bowel and colon is rare. Few cases of symptomatic colon metastasis have been reported, and it is rarely recognised clinically before severe complications occur. Our patient was a 64-year-old previously healthy male, an ex-smoker with a 20 pack-year history of smoking, who quit 4 years prior to his diagnosis of primary bronchogenic squamous cell carcinoma with local lymphatic invasion in January 2021. After two months, the patient started his scheduled treatment with multiple lines of immunochemotherapy. Follow-up in November 2022 showed disease progression, for which mediastinoscopy was performed for diagnostic evaluation, followed by palliative radiotherapy for local disease control. The patient was doing well, but after seven months, he presented to the hospital seeking medical advice due to abdominal pain and constipation for a duration of 2 weeks. A workup including a CT scan, colonoscopy, and biopsy was performed. The patient was diagnosed with poorly differentiated squamous cell carcinoma metastasis to the colon, and a right hemicolectomy was performed for palliation. In general, colonic metastasis of lung cancer is associated with a poor prognosis, with a survival range of 5 weeks to 1 year.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.